Related Experiment Video
Updated: Sep 2, 2025
12:16
A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells
Published on: October 16, 2018
14.9K
Upcoming immunotherapeutic combinations for B-cell lymphoma
Patrick Greve1,2, Friederike A G Meyer-Wentrup2, Victor Peperzak1
1Center for Translational Immunology, University Medical Center Utrecht, Utrecht, The Netherlands.
Immunotherapy Advances
|August 3, 2022
Summary
Combination immunotherapies are revolutionizing B-cell lymphoma treatment for adults and children. Future clinical trials will explore novel combinations for more personalized and effective cancer therapies.
Area of Science:
- Oncology
- Immunology
- Hematology
Background:
- Immune checkpoint inhibitors and immunotherapies initially used as adjuvant treatments for B-cell lymphomas.
- These novel therapies are now integral components of mainstream treatment regimens for both adult and pediatric patients.
Purpose of the Study:
- To provide an overview of the current status of combination therapies for B-cell lymphoma.
- To analyze combination therapy trials registered between 2015-2020 to understand treatment evolution.
Main Methods:
- In-depth analysis of clinical trials registered for B-cell lymphoma combination therapies.
- Review of treatment regimens involving chemotherapy, immunotherapy, and targeted therapy.
Main Results:
- Significant evolution in B-cell lymphoma treatment driven by new therapeutic agents.
- Combination therapies are increasingly integrated into standard care for diverse patient populations.
Conclusions:
- Upcoming clinical trials will likely employ systematic testing of novel combinations.
- Future trials will utilize basket and umbrella designs for targeted drug evaluation based on genetic profiles and immune microenvironment.
- Personalized lymphoma treatment will leverage synergistic effects of combined therapies for improved patient outcomes.
More Related Videos
Related Concept Videos
02:50Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
01:27Tumor Immunotherapy
650
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
650
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
01:22Bone Marrow Sampling and Transplants
485
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
485
01:30Cancer Vaccines
500
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
500
01:31Hybridoma Technology
15.3K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
15.3K